spacer
spacer

PDBsum entry 2ydl

Go to PDB code: 
protein links
Signaling protein PDB id
2ydl

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
67 a.a.
Waters ×56
PDB id:
2ydl
Name: Signaling protein
Title: Crystal structure of sh3c from cin85
Structure: Sh3 domain-containing kinase-binding protein 1. Chain: a. Fragment: sh3 c, residues 270-328. Synonym: cd2-binding protein 3, cd2bp3, cbl-interacting protein of 85 kda, human src family kinase-binding protein 1, hsb-1, cin85. Engineered: yes. Other_details: third sh3 domain
Source: Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 469008.
Resolution:
2.05Å     R-factor:   0.207     R-free:   0.252
Authors: J.Bravo,N.Cardenes
Key ref: J.L.Ortega Roldan et al. (2013). Distinct ubiquitin binding modes exhibited by SH3 domains: molecular determinants and functional implications. Plos One, 8, e73018. PubMed id: 24039852 DOI: 10.1371/journal.pone.0073018
Date:
22-Mar-11     Release date:   28-Mar-12    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
Q96B97  (SH3K1_HUMAN) -  SH3 domain-containing kinase-binding protein 1 from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
665 a.a.
67 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 8 residue positions (black crosses)

 Enzyme reactions 
   Enzyme class: E.C.?
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

 

 
DOI no: 10.1371/journal.pone.0073018 Plos One 8:e73018 (2013)
PubMed id: 24039852  
 
 
Distinct ubiquitin binding modes exhibited by SH3 domains: molecular determinants and functional implications.
J.L.Ortega Roldan, S.Casares, M.Ringkjøbing Jensen, N.Cárdenes, J.Bravo, M.Blackledge, A.I.Azuaga, N.A.van Nuland.
 
  ABSTRACT  
 
SH3 domains constitute a new type of ubiquitin-binding domains. We previously showed that the third SH3 domain (SH3-C) of CD2AP binds ubiquitin in an alternative orientation. We have determined the structure of the complex between first CD2AP SH3 domain and ubiquitin and performed a structural and mutational analysis to decipher the determinants of the SH3-C binding mode to ubiquitin. We found that the Phe-to-Tyr mutation in CD2AP and in the homologous CIN85 SH3-C domain does not abrogate ubiquitin binding, in contrast to previous hypothesis and our findings for the first two CD2AP SH3 domains. The similar alternative binding mode of the SH3-C domains of these related adaptor proteins is characterised by a higher affinity to C-terminal extended ubiquitin molecules. We conclude that CD2AP/CIN85 SH3-C domain interaction with ubiquitin constitutes a new ubiquitin-binding mode involved in a different cellular function and thus changes the previously established mechanism of EGF-dependent CD2AP/CIN85 mono-ubiquitination.
 

 

spacer

spacer